NTBC dosing and outcomes in hereditary tyrosinemia type 1: insights from a representative human model and 99 patients

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.